CVE:CRO 8970 (CRO.V) (CRO) Stock Price, News & Analysis → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free CRO Stock Alerts C$0.02 +0.01 (+50.00%) (As of 02/1/2018) Add Compare Share Share Today's RangeC$0.01▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.03Volume2.78 million shsAverage Volume1.53 million shsMarket CapitalizationC$2.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get 8970 (CRO.V) alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About 8970 (CRO.V)Canadian Arrow Mines Limited is a mineral exploration and development company. The Company is engaged in the business of acquiring and exploring mineral properties in Ontario, Canada. The Company operates through Canadian exploration operations segment. It is focused on developing nickel-copper sulfide deposits. The Company holds interest in certain mining claims comprising leased mining and surface claims, and patented mining rights in the Porcupine Mining Division in the Province of Ontario. The Company's principal asset is the Kenbridge project, which includes a nickel-copper sulfide deposit containing over 44,000 tons of nickel. Kenbridge Nickel Project is located in Northwestern Ontario, Canada, and lies approximately 70 Kilometers southeast of the town of Kenora on over 80 patented and approximately three staked mineral claims. The Company's Alexo and Kelex deposits are located approximately 50 Kilometers east of Timmins, Ontario.Read More CRO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRO Stock News HeadlinesDecember 6, 2023 | news.bbc.co.ukCroatia 2-0 EnglandFebruary 22, 2023 | forbes.comMcAfee vs Norton (2023 Comparison)April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 11, 2023 | finance.yahoo.comClinscience joins forces with Florida-based oncological CRO, OncoBay ClinicalJanuary 11, 2023 | benzinga.comNovotech Acquires European CRO – Strengthens Global OperationsOctober 7, 2022 | finance.yahoo.comRapid growth puts Australian CRO Accelagen on the map for clinical research globallySee More Headlines Receive CRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 8970 (CRO.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolCVE:CRO CUSIPN/A CIKN/A Webwww.canadianarrowmines.ca Phone+1-705-6738259FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares139,998,000Free FloatN/AMarket CapC$2.10 million OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesRobert Kim TylerPresident, DirectorDean G. MacEachern (Age 51)Chief Executive Officer, Director Marie-Josee Audet CPAChief Financial OfficerAlan LetourneauIndependent DirectorGeorge Edward PirieIndependent DirectorKey Competitors44605 (PTR.V)CVE:PTRWest Mountain Environmental Corp.,CVE:WMT27003 (SDS.V)CVE:SDS23895 (GKX.V)CVE:GKXSyncordia Technologies and Healthcare SolutionsCVE:SYNView All Competitors CRO Stock Analysis - Frequently Asked Questions How have CRO shares performed in 2024? 8970 (CRO.V)'s stock was trading at C$0.02 at the beginning of 2024. Since then, CRO shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. What other stocks do shareholders of 8970 (CRO.V) own? Based on aggregate information from My MarketBeat watchlists, some companies that other 8970 (CRO.V) investors own include Tahoe Resources (TAHO) and Aware (AWRE). How do I buy shares of 8970 (CRO.V)? Shares of CRO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:CRO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 8970 (CRO.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.